Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients (WONDeR)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Hypertension

Treatments: Other: Blood Sampling

Study type: Observational

Funder types: Industry

Identifiers

NCT01362283

114619

Details and patient eligibility

About

The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.

Full description

Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high risk factors

Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate Target blood pressure achievement rate according to the proportion of Cardiovascular disease risks

Enrollment: 3,109 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Essential hypertensive patient no less than 18 yeas old
• Patient who gave informed consent form

Exclusion criteria

• Patient was diagnosed as secondary hypertension
• Patient who have white-coat hypertension

Trial design

3,109 participants in 1 patient group

Hypertension

Description:

Subject who meet eligible criteria

Treatment:

Other: Blood Sampling